Skip to main content

JPMORGAN CHASE & CO

Position in RPRX — Royalty Pharma plc

CIK 19617 NEW YORK, NY

Position in RPRX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$80,573,811
+$21,894,726 QoQ
Shares Held
1,679,671
+10.6% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 78% Shared 1% None 21%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. RPRX ranks #17 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RPRX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $80,573,811 1,679,671
2025-12-31 $58,679,085 1,518,610
2025-09-30 $62,079,385 1,759,620
2025-06-30 $50,928,832 1,413,512
2025-03-31 $44,673,040 1,435,048
2024-12-31 $35,592,617 1,395,242
2024-09-30 $36,477,630 1,289,418
2024-06-30 $204,084,833 7,739,281
2024-03-31 $242,811,151 7,995,099
2023-12-31 $244,391,953 8,700,319
2023-09-30 $241,208,563 8,887,567
2023-06-30 $268,549,892 8,736,171
2023-03-31 $312,436,407 8,671,563
2022-12-31 $332,945,997 8,424,747
2022-09-30 $334,763,564 8,331,597
2022-06-30 $321,521,285 7,647,985
2022-03-31 $216,593,751 5,559,388
2021-12-31 $216,074,786 5,422,203
2021-09-30 $192,137,655 5,316,482
2021-06-30 $299,841,887 7,315,001
2021-03-31 $252,789,544 5,795,267
2020-12-31 $304,321,965 6,080,359
2020-09-30 $157,814,497 3,751,236
2020-06-30 $180,796,508 3,723,924